When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
HZNP - Biotech News Recap: Merck Announces Yet Another Successful Readout For A Key Asset
Horizon Therapeutics Public Limited Company
Merck & Co (MRK) - The company announced results from the phase 2 study of V114 (15-valent pneumococcal conjugate vaccine) as compared to currently available 13-valent pneumococcal conjugate vaccine in healthy infants 6-12 weeks of age. The primary endpoint was met by demonstrating noninferiority for the 13 serotypes contained in both vaccines. A point of differentiation is that V114 also induced an immune response in infants for two additional disease-causing serotypes (22F and 33F) which are not contained in PCV13.
Keep in mind that a few months ago this asset received the coveted